Winslow, Evans & Crocker, Inc. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2020$358,000
+6.2%
9,926
+15.2%
0.07%
-18.1%
Q3 2020$337,000
-24.9%
8,615
-29.7%
0.08%
-30.8%
Q2 2020$449,000
+131.4%
12,260
+47.7%
0.12%
+87.5%
Q1 2020$194,000
-21.8%
8,300
-1.4%
0.06%
+1.6%
Q4 2019$248,000
+8.8%
8,4160.0%0.06%
-1.6%
Q3 2019$228,000
+5.6%
8,4160.0%0.06%
+6.7%
Q2 2019$216,000
+10.2%
8,416
-2.8%
0.06%
+7.1%
Q1 2019$196,000
+6.5%
8,6560.0%0.06%
-9.7%
Q4 2018$184,000
+12.2%
8,656
-1.1%
0.06%
+24.0%
Q3 2018$164,000
-17.2%
8,7560.0%0.05%
-19.4%
Q2 2018$198,000
-99.9%
8,7560.0%0.06%0.0%
Q1 2018$192,436,000
-5.4%
8,7560.0%0.06%
-4.6%
Q4 2017$203,468,000
-9.2%
8,756
-10.3%
0.06%
-12.2%
Q3 2017$223,978,000
-3.0%
9,756
-6.7%
0.07%
+17.5%
Q2 2017$230,846,000
-3.2%
10,455
-0.0%
0.06%
-16.0%
Q1 2017$238,480,000
+9.0%
10,4560.0%0.08%
+11.9%
Q4 2016$218,720,000
-63.9%
10,456
-31.2%
0.07%
-23.0%
Q3 2016$605,516,000
+90.8%
15,206
+32.7%
0.09%
-8.4%
Q2 2016$317,420,00011,4560.10%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders